JP/ZH: Currently, only the Luminex LTG section and the Service & Support pages regarding Luminex LTG are available in Japanese/Chinese.
22/12/25 - 17:25
2026 Annual Corporate Events Calendar (117.34 KB)
22/12/25 - 17:18
Publication of documents for the Shareholders’ Meeting to be held on January 27, 2026 (144.42 KB)
22/12/25 - 14:36
The Board of Directors approved to submit to the Shareholders' Meeting the authorization for the purchase and cancellation of treasury shares for the purpose of shareholder remuneration. Ordinary and extraordinary shareholders' meeting convened. (125.84 KB)
05/11/25 - 17:46
Diasorin’s Board of Directors approves results for the first 9 months of 2025. FY 2025 Guidance revised (255.77 KB)
31/07/25 - 16:22
Revenue Growth and Margin Expansion in H1 2025. FY 2025 Guidance Confirmed (238.17 KB)
06/05/25 - 17:41
Revenue growing +8% and EBITDA margin at 34%: Q1 Results confirm FY 2025 Guidance (268.56 KB)
28/04/25 - 16:50
Shareholders' Meeting 2025 (138.81 KB)
04/04/25 - 0:59
Notice pursuant to art. 144-octied, para. 2 of CONSOB regulation No. 1971/1999 (125.78 KB)
31/03/25 - 19:36
Adoption of the enhancement of the increased voting rights mechanism: withdrawal exercised by 1.69% of the share capital. Statutory option and pre-emption offer period to start on 31 March 2025. (119.78 KB)
14/03/25 - 16:29
The Board of Directors of Diasorin SpA approves FY2024 Results with revenues and net profit in expansion compared to Previous Year; Proposed Ordinary Dividend of € 1.20 per share (239.79 KB)
03/03/25 - 21:19
Registration and publication the minutes of shareholders' meeting. Withdrawal right. (101.04 KB)
03/03/25 - 21:05
Notice to Shareholders - Information regarding the exercise of the withdrawal right (88.54 KB)
28/02/25 - 11:49
The Extraordinary Meeting of Shareholders approves the enhancement of the increased voting rights mechanism (111.6 KB)
27/01/25 - 20:14